It's an open forum for Indian Clinical and Hospital Pharmacists to discuss on designing, implementing, and monitoring a therapeutic plan that will produce specific therapeutic outcomes for the patient Eg:Antibiotic Policies, Pharmacist Interventions, Medication Therapy Management. DRP,s and Its Management.
Forum rules: Dear User, Kindly read our forum rules before you proceed with our PharmD Info, Your first 5 posts/topics requires moderator approval and this website is purely meant for educational and knowledge sharing purpose only so you should not make any topics/replies/messages which criticize, threaten or abuse any member, pharmacy governing bodies and organizations. Your post will be deleted automatically by our BB Pruning System if your topic is not viewed by members for more than 5 days. So, make sure that your topics and its related contents are unique and valuable. We expect you to be an active member of our forum to continue with your free membership.Kindly note that if a member received more than five warnings from moderator/members they will be blocked automatically by our Bulletin Board system.
Some agents have proven teratogenic potential. These agents are summarized. Although the effects of such agents are potentially variable and predictable, their use should be very limited or avoided during pregnancy.
Category D agents have proven teratogenic potential but may, under certain circumstances, be indicated. Prior to using any category D agent, providers should perform a careful review of indications, duration of therapy, all potential.effects, and all potential alternatives to the proposed therapy.
In addition,patients should be informed of these considerations, allowing for informed con- sent to the proposed therapy. Category X medications have proven teratogenic potential and use should be avoided in pregnancy